Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study
- PMID: 35082171
- PMCID: PMC8967390
- DOI: 10.1212/WNL.0000000000013275
Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study
Abstract
Background and objectives: Although flavonoids have the potential to exert neuroprotective benefits, evidence of their role in improving survival rates among individuals with Parkinson disease (PD) remains lacking. We aimed to prospectively study the association between prediagnosis and postdiagnosis flavonoid intakes and risk of mortality among individuals with PD identified from 2 large ongoing cohorts of US men and women.
Methods: Included in the current analysis were 599 women from the Nurses' Health Study and 652 men from the Health Professionals Follow-Up Study who were newly diagnosed with PD during follow-up. Dietary intakes of total flavonoid and its subclasses, together with major flavonoid-rich foods (tea, apples, berries, orange and orange juice, and red wine), were repeatedly assessed with a validated food frequency questionnaire every 4 years. Mortality was ascertained via the National Death Index and state vital statistics records.
Results: We documented 944 deaths during 32 to 34 years of follow-up. A higher total flavonoid intake before PD diagnosis was associated with a lower future risk for all-cause mortality in men (hazard ratio [HR] comparing 2 extreme quartiles 0.53, 95% confidence interval [CI] 0.39, 0.71; p for trend < 0.001) but not in women (HR 0.93, 95% CI 0.68, 1.28; p for trend = 0.69) after adjustment for age, smoking status, total energy intake, and other covariates. The pooled HR comparing the extreme quartiles was 0.70 (95% CI 0.40, 1.22; p for trend = 0.25) with significant heterogeneity (p = 0.01). For flavonoid subclasses, the highest quartile of anthocyanins, flavones, and flavan-3-ols intakes before diagnosis had a lower mortality risk compared to the lowest quartile (pooled HR 0.66, 0.78, and 0.69, respectively; p < 0.05 for all); for berries and red wine, participants consuming ≥3 servings per week had a lower risk (pooled HR 0.77, 95% CI 0.58, 1.02; and pooled HR 0.68, 95% CI 0.51, 0.91, respectively) compared to <1 serving per month. After PD diagnosis, greater consumptions of total flavonoid, subclasses including flavonols, anthocyanins, flavan-3-ols, and polymers, and berries and red wine were associated with lower mortality risk (p < 0.05 for all).
Discussion: Among individuals with PD, higher consumption of flavonoids, especially anthocyanins and flavan-3-ols, and flavonoid-rich food such as berries and red wine was likely to be associated with a lower risk of mortality.
© 2022 American Academy of Neurology.
Similar articles
-
Habitual intake of dietary flavonoids and risk of Parkinson disease.Neurology. 2012 Apr 10;78(15):1138-45. doi: 10.1212/WNL.0b013e31824f7fc4. Epub 2012 Apr 4. Neurology. 2012. PMID: 22491871 Free PMC article.
-
Dietary flavonoid intakes and risk of type 2 diabetes in US men and women.Am J Clin Nutr. 2012 Apr;95(4):925-33. doi: 10.3945/ajcn.111.028894. Epub 2012 Feb 22. Am J Clin Nutr. 2012. PMID: 22357723 Free PMC article.
-
Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts.Am J Clin Nutr. 2016 Jan;103(1):184-91. doi: 10.3945/ajcn.115.117507. Epub 2015 Nov 4. Am J Clin Nutr. 2016. PMID: 26537935 Free PMC article.
-
Flavonoid subclasses and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies.Crit Rev Food Sci Nutr. 2019;59(17):2850-2862. doi: 10.1080/10408398.2018.1476964. Epub 2019 Jan 21. Crit Rev Food Sci Nutr. 2019. PMID: 29768032 Review.
-
Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies.Br J Nutr. 2014 Jan 14;111(1):1-11. doi: 10.1017/S000711451300278X. Epub 2013 Aug 16. Br J Nutr. 2014. PMID: 23953879 Review.
Cited by
-
Dietary Flavonoid Chrysin Functions as a Dual Modulator to Attenuate Amyloid-β and Tau Pathology in the Models of Alzheimer's Disease.Mol Neurobiol. 2024 Oct 21. doi: 10.1007/s12035-024-04557-y. Online ahead of print. Mol Neurobiol. 2024. PMID: 39432184
-
Epidemiology of Parkinson's Disease: An Update.Curr Neurol Neurosci Rep. 2024 Jun;24(6):163-179. doi: 10.1007/s11910-024-01339-w. Epub 2024 Apr 20. Curr Neurol Neurosci Rep. 2024. PMID: 38642225 Review.
-
Dietary and Lifestyle Factors of Brain Iron Accumulation and Parkinson's Disease Risk.medRxiv [Preprint]. 2024 Mar 15:2024.03.13.24304253. doi: 10.1101/2024.03.13.24304253. medRxiv. 2024. PMID: 38559115 Free PMC article. Preprint.
-
Gold Nanoparticles in Parkinson's Disease Therapy: A Focus on Plant-Based Green Synthesis.Cureus. 2024 Feb 22;16(2):e54671. doi: 10.7759/cureus.54671. eCollection 2024 Feb. Cureus. 2024. PMID: 38524031 Free PMC article. Review.
-
Association of dietary flavonoid intakes with prevalence of chronic respiratory diseases in adults.J Transl Med. 2024 Feb 26;22(1):205. doi: 10.1186/s12967-024-04949-7. J Transl Med. 2024. PMID: 38409037 Free PMC article.
References
-
- Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology. 2008;70(16 Pt 2):1423-1430. - PubMed
-
- Herlofson K, Lie SA, Arsland D, Larsen JP. Mortality and Parkinson disease: a community based study. Neurology. 2004;62(6):937-942. - PubMed
-
- Ascherio A, Weisskopf MG, O'Reilly EJ, et al. . Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II cohort: the modifying effects of estrogen. Am J Epidemiol. 2004;160(10):977-984. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical